Treatment options for patients with advanced prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Stromal Cells Neoplastic Cells, Circulating

Organisms5

Mice, Nude Mice, SCID Perna Mice, Inbred BALB C Mice, Transgenic

Diseases38

Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Neoplasms, Hormone-Dependent Bone Neoplasms Prostatic Hyperplasia Adenocarcinoma Disease Progression Neoplasm Metastasis Male Urogenital Diseases Prostatic Intraepithelial Neoplasia Neoplasm Invasiveness Neoplasm Recurrence, Local Genetic Predisposition to Disease Breast Neoplasms Neoplasms Disease Models, Animal Lung Neoplasms Carcinoma Ovarian Neoplasms Colonic Neoplasms Stomach Neoplasms Pancreatic Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Prostatitis Urinary Bladder Neoplasms Colorectal Neoplasms Neovascularization, Pathologic Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Erectile Dysfunction Carcinoma, Squamous Cell Lymphatic Metastasis Liver Neoplasms Recurrence Rectal Neoplasms Neoplastic Cells, Circulating Radiation Injuries

Chemicals and Drugs68

Androgen Antagonists Prostate-Specific Antigen Tosyl Compounds Receptors, Androgen Androgens Goserelin Antineoplastic Agents, Hormonal Leuprolide Anilides Flutamide Androgen Receptor Antagonists Estramustine Tumor Markers, Biological Antineoplastic Agents Nitriles Phenylthiohydantoin Chlormadinone Acetate Gonadotropin-Releasing Hormone Cyproterone Acetate Dihydrotestosterone Taxoids Neoplasm Proteins Cancer Vaccines PTEN Phosphohydrolase Tissue Extracts RNA, Messenger Testosterone Diethylstilbestrol Antineoplastic Agents, Phytogenic Metribolone Androstenols Diphosphonates Finasteride Antigens, Neoplasm RNA, Small Interfering Anticarcinogenic Agents Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors DNA, Neoplasm Testosterone Congeners 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Proto-Oncogene Proteins c-akt Azasteroids Antibodies, Monoclonal Receptor, erbB-2 Racemases and Epimerases Tumor Suppressor Protein p53 RNA, Neoplasm MicroRNAs Transcription Factors Cholestenone 5 alpha-Reductase Tumor Suppressor Proteins Receptors, Estrogen Glutathione S-Transferase pi Paclitaxel Enzyme Inhibitors DNA-Binding Proteins Proto-Oncogene Proteins Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Prostatic Secretory Proteins Proto-Oncogene Proteins c-bcl-2 Androgen-Binding Protein Kallikreins Steroid 17-alpha-Hydroxylase DNA Primers Oncogene Proteins, Fusion Fluorouracil

Analytical, Diagnostic and Therapeutic Techniques and Equipment84

Orchiectomy Prostatectomy Neoplasm Staging Treatment Outcome Neoplasm Grading Radiotherapy, Conformal Combined Modality Therapy Prognosis Follow-Up Studies Xenograft Model Antitumor Assays Castration Brachytherapy Survival Rate Risk Factors Prospective Studies Disease-Free Survival Survival Analysis Neoplasm Transplantation Radiotherapy, High-Energy Case-Control Studies Retrospective Studies Immunohistochemistry Risk Radiotherapy Transplantation, Heterologous Early Detection of Cancer Multivariate Analysis Antineoplastic Combined Chemotherapy Protocols Reverse Transcriptase Polymerase Chain Reaction Radiotherapy Dosage Risk Assessment Proportional Hazards Models Cohort Studies Clinical Trials as Topic Blotting, Western Drug Screening Assays, Antitumor Kaplan-Meier Estimate Incidence Drug Administration Schedule Gene Expression Profiling Questionnaires Odds Ratio Predictive Value of Tests Transfection Immunotherapy Digital Rectal Examination Randomized Controlled Trials as Topic Disease Models, Animal Neoadjuvant Therapy Biopsy Transurethral Resection of Prostate Sensitivity and Specificity Biopsy, Needle Tumor Burden Chemotherapy, Adjuvant Molecular Targeted Therapy Oligonucleotide Array Sequence Analysis Registries Tissue Array Analysis SEER Program Nomograms Logistic Models Polymerase Chain Reaction Reproducibility of Results Models, Biological Mass Screening Confidence Intervals Flow Cytometry Gene Knockdown Techniques Immunoenzyme Techniques Tomography, X-Ray Computed Radiotherapy, Intensity-Modulated Genetic Therapy Palliative Care Radiotherapy Planning, Computer-Assisted Treatment Failure In Situ Hybridization, Fluorescence Patient Selection Feasibility Studies Drug Delivery Systems Clinical Trials, Phase III as Topic Real-Time Polymerase Chain Reaction Magnetic Resonance Imaging ROC Curve

Psychiatry and Psychology3

Decision Making Erectile Dysfunction Smoking

Phenomena and Processes41

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Drug Resistance, Neoplasm Cell Growth Processes Signal Transduction Genetic Predisposition to Disease Risk Time Factors Down-Regulation Genotype Cell Survival Odds Ratio Dose-Response Relationship, Drug Cell Division Diet Transfection Polymorphism, Single Nucleotide Sensitivity and Specificity Transcription, Genetic Promoter Regions, Genetic Cell Movement DNA Methylation Up-Regulation Cell Cycle Mutation Polymorphism, Genetic Nomograms Gene Silencing Gene Fusion RNA Interference Genes, Tumor Suppressor Chromosomes, Human, Pair 8 Gene Expression Base Sequence Phosphorylation Drug Synergism Alleles Phenotype Genes, Neoplasm Germ-Line Mutation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science10

Radiotherapy, Conformal Survival Rate Incidence Questionnaires Registries SEER Program Base Sequence Molecular Sequence Data Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups3

African Americans European Continental Ancestry Group Survivors

Health Care39

Treatment Outcome Follow-Up Studies Survival Rate Risk Factors Prospective Studies Disease-Free Survival Survival Analysis Case-Control Studies Retrospective Studies Risk Multivariate Analysis Risk Assessment Proportional Hazards Models Cohort Studies Clinical Trials as Topic Kaplan-Meier Estimate Incidence Questionnaires Odds Ratio Watchful Waiting Predictive Value of Tests Randomized Controlled Trials as Topic Sensitivity and Specificity Age Factors Registries National Cancer Institute (U.S.)SEER Program Nomograms Logistic Models Reproducibility of Results Mass Screening Confidence Intervals Palliative Care Treatment Failure Patient Selection Feasibility Studies Radiation Injuries Clinical Trials, Phase III as Topic ROC Curve

Geographicals3

United States Japan Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Androgen Antagonists Prostate Prostate-Specific Antigen Orchiectomy Tosyl Compounds Receptors, Androgen Androgens Goserelin Prostatic Neoplasms, Castration-Resistant Antineoplastic Agents, Hormonal Neoplasms, Hormone-Dependent Leuprolide Anilides Prostatectomy Cell Line, Tumor Flutamide Androgen Receptor Antagonists Bone Neoplasms Prostatic Hyperplasia Adenocarcinoma Gene Expression Regulation, Neoplastic Estramustine Disease Progression Neoplasm Staging Treatment Outcome Neoplasm Metastasis Neoplasm Grading Radiotherapy, Conformal Tumor Markers, Biological Combined Modality Therapy Mice, Nude Antineoplastic Agents Male Urogenital Diseases Prostatic Intraepithelial Neoplasia Nitriles Phenylthiohydantoin Chlormadinone Acetate Cell Proliferation Prognosis Follow-Up Studies Gonadotropin-Releasing Hormone Xenograft Model Antitumor Assays Cyproterone Acetate Castration Brachytherapy Dihydrotestosterone Tumor Cells, Cultured Survival Rate Apoptosis Risk Factors Taxoids Neoplasm Invasiveness Prospective Studies Drug Resistance, Neoplasm Disease-Free Survival Survival Analysis Neoplasm Proteins Cell Growth Processes Neoplasm Transplantation Radiotherapy, High-Energy Neoplasm Recurrence, Local Signal Transduction Case-Control Studies Genetic Predisposition to Disease Retrospective Studies Immunohistochemistry Risk Radiotherapy Transplantation, Heterologous Early Detection of Cancer Multivariate Analysis Cancer Vaccines PTEN Phosphohydrolase Antineoplastic Combined Chemotherapy Protocols Reverse Transcriptase Polymerase Chain Reaction United States Radiotherapy Dosage Tissue Extracts RNA, Messenger Testosterone Time Factors Risk Assessment Proportional Hazards Models Diethylstilbestrol Down-Regulation Cohort Studies Clinical Trials as Topic Blotting, Western Antineoplastic Agents, Phytogenic Quality of Life Drug Screening Assays, Antitumor Kaplan-Meier Estimate Genotype Mice, SCID Incidence Drug Administration Schedule Gene Expression Profiling Cell Survival Metribolone

No FAQ available that match "treatment options for patients with advanced prostate cancer"